Invention Grant
- Patent Title: Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities
-
Application No.: US15068926Application Date: 2016-03-14
-
Publication No.: US09643961B2Publication Date: 2017-05-09
- Inventor: Maria Prat Quinones , Silvia Fonquerna Pou , Carlos Puig Duran , Wenceslao Lumeras Amador , Jose Aiguade Bosch , Juan Francisco Caturla Javaloyes
- Applicant: Almirall, S.A.
- Applicant Address: ES Barcelona
- Assignee: Almirall, S.A.
- Current Assignee: Almirall, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: EP10382118 20100513
- Main IPC: C07D215/26
- IPC: C07D215/26 ; C07D409/14 ; A61K31/4709 ; C07D405/12 ; C07D409/12 ; C07D413/14
Abstract:
The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Public/Granted literature
- US20160264557A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES Public/Granted day:2016-09-15
Information query
